After decades of failed drug trials, two new drugs have emerged in slowing memory loss associated with Alzheimer's disease: Leqembi and Donanemab. Is the cure for Alzheimer's disease just around the corner?
In Season 2 episode 5 of the Crossover Connections with Jack Wang Podcast, we deep dive into novel Alzheimer's therapies to discuss their effectiveness, safety, and how to find out if you're at risk.
My name is Jack Wang, I'm a Scientist, KZfaqr, Podcaster, and College Professor. In 2020 I was named the Australian University Teacher of the Year.
Find out more about my work on my website: jackwang.com.au
Subscribe to my free weekly newsletter: crossoverconnections.substack...
Listen to my podcast "Crossover Connections with Jack Wang" on:
Apple Podcasts: podcasts.apple.com/au/podcast...
Spotify: open.spotify.com/show/6NbmWrC...
Google Podcasts: podcasts.google.com/feed/aHR0...
RSS feed: api.substack.com/feed/podcast...
#biolabcollective #crossoverconnections #alzheimersawareness #alzheimer
0:00 Introduction
2:00 Who's most at risk of Alzheimer's Disease?
5:52 The Amyloid Hypothesis
7:14 Leqembi approved by FDA
9:16 Donanenmab may be next
12:10 Alzheimer's drugs, brain bleeding, and death
16:01 How do you know if you have Alzheimer's?
21:20 Dementia and CTE
22:49 Do taking smart drugs make us more productive? Is it worth the risk?
27:00 The Connect - viewers' comments from previous episodes